Title | Extracellular vesicles and particles as mediators of long-range communication in cancer: connecting biological function to clinical applications. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Asao T, Tobias GCardial, Lucotti S, Jones DR, Matei I, Lyden D |
Journal | Extracell Vesicles Circ Nucl Acids |
Volume | 4 |
Issue | 3 |
Pagination | 461-485 |
Date Published | 2023 Sep |
Abstract | Over the past decade, extracellular vesicles and particles (EVPs) have emerged as critical mediators of intercellular communication, participating in numerous physiological and pathological processes. In the context of cancer, EVPs exert local effects, such as increased invasiveness, motility, and reprogramming of tumor stroma, as well as systemic effects, including pre-metastatic niche formation, determining organotropism, promoting metastasis and altering the homeostasis of various organs and systems, such as the liver, muscle, and circulatory system. This review provides an overview of the critical advances in EVP research during the past decade, highlighting the heterogeneity of EVPs, their roles in intercellular communication, cancer progression, and metastasis. Moreover, the clinical potential of systemic EVPs as useful cancer biomarkers and therapeutic agents is explored. Last but not least, the progress in EVP analysis technologies that have facilitated these discoveries is discussed, which may further propel EVP research in the future. |
DOI | 10.20517/evcna.2023.37 |
Custom 1 | |
Alternate Journal | Extracell Vesicles Circ Nucl Acids |
PubMed ID | 38707985 |
PubMed Central ID | PMC11067132 |
Grant List | U54 CA163117 / CA / NCI NIH HHS / United States R01 CA218513 / CA / NCI NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States R01 CA207983 / CA / NCI NIH HHS / United States R01 CA240472 / CA / NCI NIH HHS / United States U01 CA210240 / CA / NCI NIH HHS / United States R21 CA270998 / CA / NCI NIH HHS / United States R01 CA217169 / CA / NCI NIH HHS / United States R35 CA232093 / CA / NCI NIH HHS / United States |